All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Diego Dr. David Traver New Faculty I Genetic dissection of mesodermal commitment to the hematopoietic fates. $2,150,620
University of Southern California Dr. Songtao Shi New Faculty I Oral and Craniofacial Reconstruction Using Mesenchymal Stem Cells $3,242,651
Scripps Research Institute Dr. Sheng Ding Dr. New Faculty I Reprogramming of human somatic cells back to pluripotent embryonic stem cells $1,393,876
Gladstone Institutes, J. David Sheng Ding PhD New Faculty I Reprogramming of human somatic cells back to pluripotent embryonic stem cells $1,320,101
Stanford University Karl Deisseroth New Faculty I Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $2,424,209
Stanford University Dr. Howard Y. Chang New Faculty I Noncoding RNAs in Cell Fate Determination $2,985,894
BioTime, Inc. Dr. Michael D West Ph.D. Early Translational I Addressing the Cell Purity and Identity Bottleneck Through Generation and Expansion of Clonal Human Embryonic Progenitor Cell Lines $4,721,706
University of California, Davis Dr. Alice F Tarantal Early Translational I In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies $3,143,392
Salk Institute for Biological Studies Dr. Inder M. Verma Early Translational I Curing Hematological Diseases $5,979,252
Sanford Burnham Prebys Medical Discovery Institute Dr Evan Y Snyder Early Translational I Developmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD) $5,190,752
Stanford University Dr. Jill Helms Early Translational I Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,464,126
Jackson Labs Pali G. Kaur Early Translational I Mouse Models for Stem Cell Therapeutic Development $3,759,134
Gladstone Institutes, J. David Dr. Warner C Greene Early Translational I Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation $1,280,001
Scripps Research Institute Dr. Martin Friedlander Early Translational I Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration $5,806,321
University of California, Los Angeles Dr. Gabriel H. Travis Early Translational I Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration $5,487,136
Scripps Research Institute Dr. Jeanne F Loring Early Translational I Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation $5,830,771
ViaCyte, Inc. Dr. Olivia G. Kelly Early Translational I Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product $5,405,397
Scripps Health Dr. Darryl D. D’Lima Early Translational I Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis $3,118,431
University of California, Irvine Dr. Frank LaFerla Early Translational I Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease $3,599,997
University of California, Davis Dr. Jan Aileen Nolta PhD Early Translational I Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders $2,615,674
University of California, San Diego Dr. Yang Xu Early Translational I Developing induced pluripotent stem cells into human therapeutics and disease models $5,165,028
Parkinson’s Institute Mr. James “Bill” William Langston Mr. Early Translational I Using patient-specific iPSC derived dopaminergic neurons to overcome a major bottleneck in Parkinson’s disease research and drug discovery $3,698,646
University of California, Berkeley Dr. Ellen A. Robey Transplantation Immunology Human Immune System Mouse models as preclinical platforms for stem cell derived grafts $1,005,605
Scripps Research Institute Dr. Nicholas R.J. Gascoigne Transplantation Immunology Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance $1,705,554
Stanford University Dr. Ken Weinberg Transplantation Immunology Engineered immune tolerance by Stem Cell-derived thymic regeneration $1,271,729
University of California, Berkeley Dr. David H Raulet Transplantation Immunology Inactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue $952,896
Stanford University Dr. Robert Negrin MD Transplantation Immunology Regulatory T cell induced tolerance to ESC transplantation $1,382,658
University of California, San Diego Prof. Martin Marsala Transplantation Immunology Induction of immune tolerance after spinal grafting of human ES-derived neural precursors $1,387,800
Cedars-Sinai Medical Center Dr. Terrence Town Transplantation Immunology Role of HLA in neural stem cell rejection using humanized mice $1,119,385
University of Southern California Dr. Terrence Christopher Town Transplantation Immunology Role of HLA in neural stem cell rejection using humanized mice $353,249
Stanford University Professor Christopher H. Contag Transplantation Immunology Engineering Embryonic Stem Cell Allografts for Operational Tolerance $1,411,338
University of California, San Diego Dr. Yang Xu Transplantation Immunology Induction of immune tolerance to human embryonic stem cell-derived allografts $1,192,680
University of California, Los Angeles Dr. Gay Miriam Crooks Transplantation Immunology Engineering Thymic Regeneration to Induce Tolerance $1,235,445
University of California, Davis Dr. William J Murphy Transplantation Immunology Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance $1,257,601
Palo Alto Veterans Institute for Research Dr. Husein Hadeiba Transplantation Immunology Application of Tolerogenic Dendritic Cells for Hematopoietic Stem Cell Transplantation $733,061
Escape Therapeutics, Inc Basil M Hantash Transplantation Immunology Development of an immune tolerant hESC source for allogeneic cell therapy applications $1,453,040
La Jolla Institute for Allergy and Immunology Dr. Anjana Rao Transplantation Immunology Generation of regulatory T cells by reprogramming $1,464,446
University of California, San Francisco Dr. Tippi C. Mackenzie MD Transplantation Immunology Maternal and Fetal Immune Responses to In Utero Hematopoietic Stem Cell Transplantation $1,230,869
Scripps Research Institute Dr. Jeanne F Loring Transplantation Immunology Thymus based tolerance to stem cell therapies $1,108,921
Stanford University Dr. Judith A Shizuru Transplantation Immunology Purified allogeneic hematopoietic stem cells as a platform for tolerance induction $1,233,275
University of California, San Francisco Dr. Jeffrey A Bluestone Transplantation Immunology Stem cell tolerance through the use of engineered antigen-specific regulatory T cells $1,152,768
University of California, San Francisco Dr. Mark S. Anderson Transplantation Immunology Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells $1,314,089
University of California, San Diego Dr. Ying Liu Tools and Technologies I Generation of disease models for neurodegenerative disorders in hESCs by gene targeting $709,829
University of California, Davis Kit S Lam Tools and Technologies I Discovery of adhesion ligands for pluripotent human stem cells $834,003
ViaCyte, Inc. Dr. Evert Kroon Tools and Technologies I Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors. $827,072
University of California, Irvine Dr. Lisa A Flanagan Tools and Technologies I Novel Separation of Stem Cell Subpopulations $861,122
University of California, Berkeley Dr. Steven M. Conolly Tools and Technologies I Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo $858,345
University of Southern California Dr. Pin Wang Tools and Technologies I Development of Baculoviral Vectors for Gene Editing of Human Stem Cells $945,604
Gamma Medica-Ideas, Inc. Douglas Jay Wagenaar Tools and Technologies I A Novel SPECT Microscopy System for 3D Imaging of Single Stem Cells In Vivo $800,065
University of California, Davis Dr. Alice F Tarantal Tools and Technologies I In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates $799,350